To interrogate the clinical significance of TAM infiltration and PTN expression in GBMs, we used the Cancer Genome Atlas (TCGA) database to analyse the potential associations between GBM patient survival and the expression of pan TAM marker Iba1, the M2 TAM marker CD163 or PTN. The gene discussed is AIF1; the disease is glioblastoma.